Center-Authored Papers

Filters: Author is Muss, Hyman B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y et al..  2013.  Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.. Journal of the National Cancer Institute. 105(14):1036-1042. Abstract
R
Rugo HS, Rumble BR, Macrae E, Barton DL, Connolly HK, Dickler MN, Fallowfield L, Fowble B, Ingle JN, Jahanzeb M et al..  2016.  Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(25):3069-103. Abstract
M
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP et al..  2009.  Adjuvant chemotherapy in older women with early-stage breast cancer.. The New England journal of medicine. 360(20):2055-65. Abstract
Moye VA, Chandramouleeswaran S, Zhao N, Muss HB, Weissler MC, Hayes DN, Zevallos JP.  2015.  Elderly patients with squamous cell carcinoma of the head and neck and the benefit of multimodality therapy.. The oncologist. 20(2):159-65. Abstract
L
Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff AC, Gralow J, Morganstern DE, Magrinat G, Cohen HJ et al..  2016.  Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
G
Goss PE, Hershman DL, Cheung AM, Ingle JN, Khosla S, Stearns V, Chalchal H, Rowland K, Muss HB, Linden HM et al..  2014.  Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.. The lancet oncology. 15(4):474-82. Abstract